P153 Tocilizumab in systemic sclerosis: real world experience from a single centre cohort supports potential benefit on lung function for anti-topoisomerase (Scl-70) positive subgroup (2020)

First Author: Denton C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa111.148

Publication URI: http://dx.doi.org/10.1093/rheumatology/keaa111.148

Type: Journal Article/Review

Parent Publication: Rheumatology

Issue: Supplement_2